Multi-faceted characterization of mesenchymal stem cells and their application as a powerful tool for agrobiotechnology, assisted reproductive technologies, and veterinary and regenerative biomedicine-Reference-Cited by-全球学者库

Multi-faceted characterization of mesenchymal stem cells and their application as a powerful tool for agrobiotechnology, assisted reproductive technologies, and veterinary and regenerative biomedicine

Published:2023-05-25 Issue:0 Volume:0 Page:
ISSN:2300-8733
Container-title:Annals of Animal Science
language:en
Short-container-title:

Author:

Romanek Joanna¹^ORCID,Trzcińska Monika¹^ORCID,Samiec Marcin¹^ORCID

Affiliation:

1. 1 Department of Reproductive Biotechnology and Cryoconservation , National Research Institute of Animal Production , 32-083 Balice n. Kraków , Poland

Abstract

Abstract A broad spectrum of cytologically specific immunophenotypic, biochemical, physiological and molecular attributes of neonatal and adult mesenchymal stem cells (MSCs) exists. Taking into account the biological traits of these types of multipotent stem cells, they play a pivotal role in the wide utilization of MSC-mediated engineering and MSC-based assisted reproductive technologies (ARTs) for animal production, veterinary research, regenerative and reconstructive medicine, and cell/tissue transplantology. Consequently, this paper sought to comprehensively provide research highlights, and insightful interpretation of current goals and future targets related to the agricultural, embryological and biomedical application of MSC-assisted biotechnological strategies and MSC-dependent interdisciplinary research techniques.

Publisher

Walter de Gruyter GmbH

Link

https://www.sciendo.com/pdf/10.2478/aoas-2023-0055

Reference101 articles.

1. Abdalmula A., Dooley L.M., Kaufman C., Washington E.A., House J.V., Blacklaws B.A., Ghosh P., Itescu S., Bailey S.R., Kimpton W.G. (2017). Immunoselected STRO-3+ mesenchymal precursor cells reduce inflammation and improve clinical outcomes in a large animal model of monoarthritis. Stem Cell Res. Ther., 8: 22.

2. Al Faqeh H., Nor Hamdan B.M., Chen H.C., Aminuddin B.S., Ruszymah B.H. (2012). The potential of intra-articular injection of chondrogenic-induced bone marrow stem cells to retard the progression of osteoarthritis in a sheep model. Exp. Gerontol., 47: 458–464.

3. Almalki S.G., Llamas Valley Y., Agrawal DK. (2017). MMP-2 and MMP-14 Silencing Inhibits VEGFR2 Cleavage and Induces the Differentiation of Porcine Adipose-Derived Mesenchymal Stem Cells to Endothelial Cells. Stem Cells Transl. Med., 6: 1385–1398.

4. Al-Najar M., Khalil H., Al-Ajlouni J., Al-Antary M., Hamdan M., Rahmeh R., Alhattab D., Samara O., Yasin M., Al Abdullah A., Al-Jabbari E., Hmaid D., Jafar H., Awidi A. (2017). Intra-articular injection of expanded autologous bone marrow mesenchymal cells in moderate and severe knee osteoarthritis is safe: a phase I/II study. J. Orthop. Surg. Res., 12: 190.

5. Araújo A.B., Salton G. D., Furlan J.M., Schneider N., Angeli M.H., A.M., Silla L., Eduardo Passos P., Paz A.H. (2017). Comparison of human mesenchymal stromal cells from four neonatal tissues: Amniotic membrane, chorionic membrane, placental decidua and umbilical cord. Cytotherapy, 19: 577–585.